Thus, silencing of NOX1 expression significantly reduced typical molecular features of PD, such as α-synuclein protein aggregation and high α-synuclein ubiquitin expression levels, in a drug-induced model of PD [308,309]. Here, NOX1 is linked to Parkinson disease.